InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.00
(
0.00%
)
Bitcoin
58,004.01
(
-1.64%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5488
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: charthawk post# 9283

Monday, 02/13/2012 4:05:50 PM

Monday, February 13, 2012 4:05:50 PM

Post# of 26138
Teva only has right to the Bio-t-gel in the US, the right to the rest of the world still belong to Biosante. So yes approval will mean something to BPAX. In all likelihood Teva would negotiate a new licencing agreement which would be more profitable for BPAX for the remaining rights. Teva has around 47,000 employees in over 60 countries. Feb 14th PDUFA is about BPAX getting the foot in the door.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up